1. Home
  2. CAN vs TECX Comparison

CAN vs TECX Comparison

Compare CAN & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • TECX
  • Stock Information
  • Founded
  • CAN 2013
  • TECX 2019
  • Country
  • CAN Singapore
  • TECX United States
  • Employees
  • CAN N/A
  • TECX N/A
  • Industry
  • CAN Semiconductors
  • TECX
  • Sector
  • CAN Technology
  • TECX
  • Exchange
  • CAN Nasdaq
  • TECX Nasdaq
  • Market Cap
  • CAN 384.3M
  • TECX 334.4M
  • IPO Year
  • CAN 2019
  • TECX 2018
  • Fundamental
  • Price
  • CAN $0.73
  • TECX $20.97
  • Analyst Decision
  • CAN Strong Buy
  • TECX Buy
  • Analyst Count
  • CAN 6
  • TECX 6
  • Target Price
  • CAN $2.67
  • TECX $78.67
  • AVG Volume (30 Days)
  • CAN 29.1M
  • TECX 234.2K
  • Earning Date
  • CAN 08-14-2025
  • TECX 08-13-2025
  • Dividend Yield
  • CAN N/A
  • TECX N/A
  • EPS Growth
  • CAN N/A
  • TECX N/A
  • EPS
  • CAN N/A
  • TECX N/A
  • Revenue
  • CAN $317,009,000.00
  • TECX N/A
  • Revenue This Year
  • CAN $160.28
  • TECX N/A
  • Revenue Next Year
  • CAN $35.68
  • TECX N/A
  • P/E Ratio
  • CAN N/A
  • TECX N/A
  • Revenue Growth
  • CAN 65.68
  • TECX N/A
  • 52 Week Low
  • CAN $0.53
  • TECX $13.70
  • 52 Week High
  • CAN $3.27
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • CAN 57.95
  • TECX 49.87
  • Support Level
  • CAN $0.58
  • TECX $20.39
  • Resistance Level
  • CAN $0.77
  • TECX $21.40
  • Average True Range (ATR)
  • CAN 0.05
  • TECX 1.13
  • MACD
  • CAN 0.02
  • TECX 0.06
  • Stochastic Oscillator
  • CAN 78.19
  • TECX 85.82

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: